共 257 条
[1]
Sledge GW(2005)What is targeted therapy? J Clin Oncol 23 1614-1615
[2]
Soria JC(2011)Added value of molecular targeted agents in oncology Ann Oncol 22 1703-1716
[3]
Blay JY(2013)Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement Clin Pharmacokinet 52 399-414
[4]
Spano JP(2013)Adherence to targeted oral anticancer medications Discov Med 15 231-241
[5]
Pivot X(2008)NCCN Task Force Report: Oral chemotherapy J Natl Compr Cancer Netw 6 S1-S14
[6]
Coscas Y(2013)Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma Leuk Lymphoma 54 683-687
[7]
Khayat D(2010)Targeting histone deacetylases: development of vorinostat for the treatment of cancer Epigenomics 2 457-465
[8]
Stuurman FE(2013)A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer Cancer Res 73 4599-4605
[9]
Nuijen B(2009)Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma N Engl J Med 361 947-957
[10]
Beijnen JH(2012)Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial Lancet Oncol 13 239-246